IL-21 is a type-I cytokine that has pleiotropic immuno-modulatory effects. Primarily produced by activated T cells including NKT and T FH cells, IL-21 plays a pivotal role in promoting T FH differentiation through poorly understood cellular and molecular mechanisms. Here, employing a mouse model of influenza A virus (IAV) infection, we demonstrate that IL-21, initially produced by NKT cells, promotes T FH differentiation by promoting the migration of late activator antigen presenting cell (LAPC), a recently identified T FH inducer, from the infected lungs into the draining lymph nodes (dLN). LAPC migration from IAV-infected lung into the dLN is CXCR3-CXCL9 dependent. IL-21-induced TNF-a production by conventional T cells is critical to stimulate CXCL9 expression by DCs in the dLN, which supports LAPC migration into the dLN and ultimately facilitates T FH differentiation. Our results reveal a previously unappreciated mechanism for IL-21 modulation of T FH responses during respiratory virus infection.
Introduction
Following infection with pathogenic microorganisms, the encounter of B cells with their cognate specific Ag in secondary lymphoid organs triggers B cell activation, proliferation and differentiation ultimately resulting in germinal center (GC) formation within B cell follicles. The GC response is particularly pronounced due to the inflammatory stimulus produced by the invading microorganisms. GC B cell responses and GC formation is largely T cell dependent. Hallmarks of the GC response include BcR affinity maturation, plasma cell differentiation and the generation of memory B cells. Hence, the GC response not only contributes to pathogen clearance but also plays a pivotal role in preventing subsequent infections with the infecting microorganism [1] [2] [3] [4] [5] .
T FH T cells are recently recognized as a distinct CD4
+ T cell subset defined as PD1 + CXCR5 + Bcl-6 + . This T-cell subset has been implicated as a key regulator of the GC B cell response through the delivery of multiple soluble and cell-associated signals to GC B cells including the production of soluble factors (IL-4 and IL-21) and the display of co-stimulatory ligands and receptors (ICOS, CD28, CD40L and CD84) [4, [6] [7] [8] [9] [10] .
The factors controlling T FH differentiation are not as yet fully understood, and multiple cell types and molecules have been implicated in this process [4, 6] . IL-21 was initially proposed as a key soluble factor driving the differentiation of Ag-primed CD4 + T cells along the T FH lineage pathway [8, 11] , and is now recognized as promoting an optimal T FH response [12, 13] . However, the mechanism(s) by which IL-21 optimizes the T FH response has not as yet been clearly defined.
Recently, we have identified a novel immune cell population in virus infected murine lungs with migratory properties and antigen presenting capacity, the late activator antigen presenting cell (LAPC) [14] . The mPDCA1
+

CD11c
2 B220 2 TcRb 2 LAPCs initiate their migration out of the IAV-infected lungs into the draining lymph nodes relatively late in the course of infection (i.e., between 6-12 days post-infection (d.p.i.)) via CXCR3-CXCL9 dependent chemotactic pathway. In the dLN, LAPCs promote T FH differentiation of Ag-activated CD4 + T cells by display of ICOSL and engagement of ICOS receptor on the activated CD4 + T cells [14] [15] [16] . In this report we demonstrate that IL-21, initially produced by NKT cells, promotes optimal T FH differentiation by augmenting CXCR3-CXCL9 dependent LAPC migration into the dLN during influenza A virus (IAV) infection. IL-21-induced TNF-a production by conventional T cells is critical to stimulate CXCL9 expression by DCs in the dLN, which supports LAPC migration into the dLN and ultimately facilitates T FH differentiation.
Materials and Methods
Mice, virus and infections
CD45.1
+ or CD45.2 + C57BL/6 mice were purchased from National Cancer Institute (NCI). Tnf-a 2/2 mice were generated in the Ludwig Institute for Cancer Research, purchased from Taconic farms and bred in house. Il-21ra 2/2 , il-21 2/2 , and OT-II mice were bred in house. Cd-1d 2/2 mice were provided by M.D. Okusa (University of Virginia, Charlottesville, VA). All mice were housed in a specific pathogen-free environment and all mouse experiments were performed in accordance with protocols approved by the University of Virginia Animal Care and Use Committee. A/WSN/OVA-II virus was generously provided by Dr. David Topham (University of Rochester, Rochester, USA) [18] . For virus infection, mice were infected intranasally (i.n.) with a sub-lethal dose (0.05 LD 50 ) of influenza strain A/PR/8/34 (H1N1), A/WSN/33 (H1N1) or A/WSN/OVA-II in serum-free Iscove's medium, after anesthesia with ketamine and xylazine.
Quantitative RT-PCR dLN cell suspensions were prepared as described [14, 15] . DCs were isolated by FACS (Reflection HAPS 2) to examine cxcl-9 expression. mRNA isolation, reverse transcription and real-time PCR were performed as previously described [19] . Data were generated with the comparative threshold cycle method, by normalizing to hypoxanthine phosphoribosyltransferase (hprt). The sequences of primers used in the studies are available on request. 
Bone marrow chimeras
Antibodies and FACS-analysis
All antibodies were purchased from BD Biosciences or eBioscience (unless otherwise stated): CD4 (L3T4), CD8a (53-6.7), CD11c (HL3), CD45.1 (A20), CD45.2 (104), CD90.2 (30-H12), B220/CD45R (RA3-6B2), NK1.1 (PK136), TCR-b (H57-597), IL-21 (FFA21), CXCR5 (2G8), PD-1 (RMP1-30), ICOS-L (HK5.3), TNF-a (MP6-XT22) and CXCL9 (MIG-2F5.5). amPDCA-1 mAb (JF05-1C2.4.1) was purchased from Miltenyi Biotec. A CXCR3 specific mAb was obtained from both R&D Systems (220803) and Biolegend (CXCR3-173). amTNF-a mAb (XT3.11) were purchased from BioXcell for in vivo mTNF-a blocking experiments. Flow cytometry was performed on FACSCanto with optimal compensation set for six-color staining. The data were analyzed using FlowJo software (Tree Star, Inc.). All cytokine (IL-21 and TNF-a) and chemokine (CXCL9) expressions by dLN-derived cells were measured directly ex vivo without further in vitro re-stimulation.
In vivo migration assay
Both B6 and il-21ra 2/2 mice were anesthetized as described above and infected by i.n. instillation with 50 ml PBS containing 0.05 LD 50 A/PR/8/34 virus. On day 5 p.i., mice received 50 ml of either PBS (negative control) or FITC-Dextran (40 kDa, 1 mg/ml) by i.n. instillation. At 24 hrs post-treatment, mice were sacrificed and cells were collected from the dLN. FACS-analysis was performed to examine the percent population of FITC + cells, gating on LAPCs (mPDCA-1 + CD11c 2 B220 2 TCRb 2 ).
In vivo TNF-a blocking experiments
To examine the role of TNF-a in LAPC-mediated T FH differentiation, in vivo TNF-a blocking experiments were performed. Briefly, B6 mice infected with 0.05LD 50 
IAV-specific antibody ELISA
BAL fluid was collected from IAV-infected mice on 8 d.p.i. by intra-tracheal instillation of 500 ml of sterile PBS, and antiinfluenza antibody responses in the BAL fluid were measured by ELISA. Briefly, wells of 96-well plates were coated overnight at room temperature with 50 ml of either A/PR/8 or B/Lee influenza virus. The plates were washed twice with PBS supplemented with 0.05% Tween-20 (PBST) and incubated with 50 ml of 2% BSA in PBST for 1 hr at room temperature. After washing the plates with PBST, 50 ml of diluted BAL fluid was added to each well and incubated for 2 hrs at room temperature.
Bound antibodies were detected by the incubation of horseradish peroxidase (HRP)-conjugated anti-mouse IgM (1:10,000; SouthernBiotech) or total IgG (1:10,000; SouthernBiotech) antibodies. After 1 hr, the plates were washed with PBST, and 100 ml of 3,39,5,59-tetramethylbenzidine (TMB) substrate solution (SigmaAldrich) was added into each well and incubated for a further 30 minutes. The enzyme reaction was stopped by adding 100 ml of 2N H 2 SO 4 and O.D. values were determined at 450 nm using a plate reader (Bio-TEK).
Statistical analysis
Unless otherwise noted, an unpaired two-tailed Student's t-test was used to compare two treatment groups. Groups larger than two were analyzed with one-way ANOVA (Tukey's post-test). These statistical analyses were performed using Prism3 software (for Macintosh; GraphPad Software, Inc.). Data are mean 6 s.e.m. A p value of ,0.05 was considered to be statistically significant.
Results
IL-21 can promote T FH differentiation in CD4
+ T cells lacking an IL-21 receptor + PD1 + CXCR5 + Thy1.2 + ) was monitored in the dLN by FACS-analysis. As previously shown in BALB/c mice [16] , in the uninfected mice the number of T FH cells was negligible. T FH T cells were first detected at 6 d.p.i. and showed the accumulation (absolute number) of T FH cell in the dLN was maximum at 12 d.p.i. (Fig. 1a) . The kinetics of T FH expansion and contraction do differ modestly from that reported by Boyden et al. [20] . The most likely explanation for this difference is the virus infectious dose since Boyden et al. used 0.1 LD 50 A/PR/8/34 virus.
To examine whether IL-21 is necessary for optimal T FH differentiation in IAV infection, we evaluated the generation/ accumulation of T FH cells in the dLN of IAV infected il-21ra deficient (il-21ra 2/2 ), il-21 deficient (il-21 2/2 ) and wild type (WT) mice. As reported previously [8, 12, 13] (Fig. 1b) . These results suggest that in IAV infection IL-21 activity may be necessary to support optimal T FH differentiation. Correlated with diminished T FH response, at 8 d.p.i. IAV-infected il21ra 2/2 mice exhibited significantly diminished both germinal center (GC)-B cell (Fig. 1c) and anti-IAV antibody responses (Fig. 1d ) compared to wild type mice.
At present, it is uncertain whether IL-21 supports T FH differentiation primarily through direct engagement of the IL-21 receptor (IL-21R) on activated proliferating CD4 + T cells or if other indirect mechanisms of IL-21 action also play a role [12, 21] . To address this issue during IAV infection, we constructed mixed bone marrow (BM) chimera in which lethally irradiated (1,100 rads) C57BL/6 mice (WT: CD45.1 + ) were reconstituted with a one-to-one mixture of BM from CD45. 
2 ) were most prominent cell type producing IL-21 in the dLN of IAV-infected C57BL/6 mice ( Fig. 2c ). This data was further confirmed using a mouse model lacking NKT cells (cd-1d 2/2 mice) showing that at 6 d.p.i. both protein and gene expressions of IL-21 in the dLNs were significantly impaired in IAV-infected cd-1d 2/2 mice compared to wild type mice ( Fig. 2d and 2e ). Since IL-21 promotes T FH differentiation of CD4 T cells during IAV infection and NKT cells are initial primary source of IL-21 in the dLN, we determined T FH response in the dLN of IAV-infected cd1d 2/2 mice and found that at 8d.p.i. IAV-infected cd-1d 2/2 mice exhibited significantly diminished T FH response compared to wild type mice (Fig. 2f) . Together, these data suggest that at the early phase of T FH development following IAV infection NKT cells may serve as an initial major (primary) source of IL-21 in the dLN.
Recently, we have identified a novel migratory immune cell type, LAPC, in the respiratory track of IAV-infected mice [14] . LAPCs unlike conventional APCs such as respiratory dendritic cells (DCs) migrate from the infected lung tissue into the dLN late, i.e. starting at 6 d.p.i. during IAV infection and have been demonstrated to promote the differentiation of Ag-primed activated CD4
+ T cells along the T FH differentiation pathway [14] [15] [16] . As with IL-21 production, the kinetics of LAPC accumulation in the dLN directly parallels T FH accumulation in the dLN (Fig. 1a , 2a, 2b and 2g).
IL-21 receptor signaling modulates LAPC migration from lung tissue into the dLN of IAV-infected mice
Since in the mixed bone marrow (BM) chimera the absence of the IL-21R on the responding anti-viral CD4 + T cells did not diminish the generation of CD4 + T FH T cells in the dLN but the kinetics of IL-21 expression paralleled with LAPC accumulation in the dLNs, we considered the possibility of IL-21 expression and mice. Interestingly, il-21ra 2/2 mice showed significantly diminished FITC positive LAPC accumulation in the dLN at 6 d.p.i. compared to wild type mice (Fig. 3a) . Although we cannot formally exclude the possibility that the diminished accumulation of FITC positive LAPC from il-21ra 2/2 mice in the dLN at day 5-6 p.i reflects defective uptake of FITC-dextran in the lung by LAPC deficient in IL-21R signaling, diminished LAPC accumulation in the dLN of both il-21ra
2/2 and il-21 2/2 mice in terms of absolute LAPC numbers suggests that IL-21/IL-21R signaling plays a pivotal role in the migration of LAPCs from IAV-infected lungs into the dLN (Fig. 3b) . Since NKT cells are the initial primary source of IL-21 in the dLN of IAV-infected mice ( Fig. 2d  and 2e ), the mice lacking NKT cells (cd-1d 2/2 mice) showed significantly diminished LAPC accumulation in the dLNs comparable to that of il-21ra 2/2 mice at 8 d.p.i. (Fig. 3b) . To determine if the deficit in LAPC migration in mice deficient in the IL-21 receptor was attributable to a defect in the expression of this receptor by LAPC, we constructed mixed bone marrow (BM) chimeras in which mice were reconstituted with a one-to-one mixture of BM from CD45.1 + il-21ra +/+ and CD45.2
mice. Eight weeks after BM reconstitution, mice were infected with IAV and at 8 d.p.i. the frequency of wild type (CD45.1 + ) and il-21ra 2/2 (CD45.2 + ) LAPCs in the dLN were determined (Fig. 3c) . Notably, at 8 d.p.i. the ratio of wild type (CD45.1
LAPCs was comparable and equivalent to that of total dLN cells. These results suggest that IL-21 modulates LAPC migration from infected lung tissue into the dLN independently of IL-21R signaling in LAPCs.
We recently reported that ICOS-L expression by LAPC and the engagement of ICOS on CD4 + T cells is required for LAPC to promote T FH differentiation [16] . We therefore wanted to determine whether IL-21 not only affects LAPC migration into the dLN but also directly enhances the capacity of LAPC to facilitate T FH differentiation by up-regulating ICOS-L expression on LAPC. We found, however, that LAPCs isolated from the dLN of il-21ra 2/2 mice showed comparable level of ICOS-L expression to that of LAPCs from wild type mice (Fig. 3d) IL-21 enhances CXCL9 expression by DCs in the dLN of IAV-infected mice by an IL-21R independent mechanism LAPC in the IAV-infected lungs express CXCR3 and the migration of the cells from the lungs into the dLN is CXCL9 dependent [16] . Since IL-21 promotes LAPCs migration into the dLN, we questioned whether CXCR3 and/or CXCL9 expression was regulated by IL-21 receptor signaling during IAV infection. We observed that at the peak of LAPC accumulation in the infected lungs i.e. 6 d.p.i. when the LAPC initiate migration into the dLN [14] , LAPC isolated from the lungs of infected wild type and il21ra 2/2 mice expressed CXCR3 at comparable levels (Fig. 4a) . By contrast, the expression of CXCL9 in the 6 d.p.i. dLN, which is largely restricted to CD45 + cells primarily DC (Fig. 4b and [16] ), is substantially diminished in DCs from the dLN of infected il-21ra 2/2 mice ( Fig. 4c and 4d) . Importantly, compared to wild type DC, CXCL9 expression was likewise decreased in DC isolated from 6 d.p.i. dLN of infected il-21 2/2 mice (Fig. 4d) . IAV-infected cd-1d 2/2 mice, deficient for the initial primary source of IL-21, NKT cell, also showed significantly diminished expression of CXCL9 in DCs comparable to that of il-21 2/2 mice (Fig. 4d) . Of note, the gene encoding cxcl-10, another CXCR3 ligand, was not expressed in the dLN of wild type mice during the course of IAV infection (unpublished data).
To directly address the impact of IL-21R signaling in dLN DCs on CXCL9 expression by these cells, we employed the CD45.1 + il21ra +/+ and CD45.2 + il-21ra 2/2 mixed bone marrow (BM) chimera strategy described above (Fig. 3) . After BM reconstitution, mice were infected with IAV and at 6 d.p.i. the CXCL9 expression levels by wild type (CD45.1 + ) and il-21ra [26] [27] [28] . TNF-a is well recognized as a critical regulator for immune and inflammatory cell migration into tissues through its capacity to enhance the expression of a variety of chemokines including CXCL9 [29] [30] [31] . It was therefore of interest to determine whether TNF-a was expressed in the dLN of IAVinfected mice at 6 d.p.i. and also to identify the cell type(s) producing TNF-a. This analysis revealed that TNF-a production in the dLN, analyzed by intracellular cytokine staining directly ex vivo, was restricted primarily to conventional T-cells (7.6% of total T cells) and to a lesser extent to NKT cells (5% of total NKT cells) (Fig. 5a ). However, in terms of absolute cell number T cells are predominant producers for TNF-a in the dLN at 6 d.p.i. Both CD4 + and CD8 + T cells in the 6 d.p.i. dLN expressed TNF-a (i.e. ,7-8% of the respective T-cells subset) (Fig. 5b) . It is also noteworthy that the T-cells from the corresponding dLN of IAV-infected il-21 2/2 mice exhibited a significantly diminished protein expression of TNF-a compared to infected wild type mice both in terms of the percentage of each subset and absolute cell numbers (Fig. 5b) . To further confirm the contribution of IL-21R signaling in TNF-a expression by IAV-activated T cells, mixed BM chimeras containing wild type (CD45.1 + ) and il-21ra 2/2 (CD45.2 + ) BM in a 1:1 ratio were generated. After 8 weeks, the successfully reconstituted mice were infected with A/PR/8/34 IAV. Since TNF-a expression can be regulated both pre-and post-transcriptionally, on 6 d.p.i. both wild type (CD45.1 + ) and il-21ra 2/2 (CD45.2 + ) T cells (both CD4 and CD8 T cells) were isolated from the dLN by FACS and tnf-a gene expression in sorted T cells was determined by qPCR. As shown in figure.5c, il-21ra 2/2 T cells (both CD4 and CD8 T cells) exhibited significantly diminished tnf-a gene expression compared to WT-T cells (Fig. 5c ). Of note, IL-21 deficiency had no impact on TNF-a production by NKT cells in the 6 d.p.i. dLN of il-21 2/2 mice (data not shown). However, since NKT cells are the initial primary source of IL-21 in the 6 d.p.i. dLNs, IAV-infected cd-1d 2/2 mice exhibited significantly diminished expression of TNF-a in conventional T cells compared to wild type mice at 6 d.p.i. (Fig. 5d) . Finally, these data all together suggest that IL-21, initially produced by NKT cells, promotes TNF-a production by conventional T cells via IL-21R stimulation in the dLN of IAV-infected mice.
TNF-a produced by T cells promotes CXCL9-mediated LAPC migration into the dLN and subsequent T FH differentiation during IAV infection
In view of the above results it was of interest first to determine if TNF-a influenced the production of CXCL9 by DCs in the dLN and thereby the migration of LAPC from the infected lungs to the dLN and subsequent T FH cell accumulation. To this end IAVinfected mice were treated by i.p. with either amTNF-a neutralizing mAbs (XT3.11) or isotype control Abs (Rat IgG) over time frame including the initial migration of LAPC into the dLN i.e. between 4 d.p.i and 7 d.p.i. (Fig. 6a) . The level of CXCL9 expression by dLN DCs was evaluated directly ex vivo 24 hrs later by flow cytometric analysis. In vivo neutralization of TNF-a resulted in a significant decrease in CXCL9 production by DCs (Fig. 6b) . In parallel with the decrease in CXCL9 expression, we observed that the accumulation of both LAPC and T FH cells in the dLN were significantly diminished in the IAV-infected mice following TNF-a neutralization as reflected in both the absolute numbers of these two cell types and their percentage within the dLN (Fig. 6c) . Next, we examined whether IAV-infected tnf-a 2/2 mice displayed a phenotype comparable to that of mice in which TNF-awas neutralized in vivo by neutralizing amTNF-a mAb administration and whether the transfer of TNF-a producing T cells into tnf-a 2/2 mice could rescue the phenotype of these mice (Fig. 7a) . Indeed, compared to wild type mice IAV-infected tnfa 2/2 mice showed significantly diminished CXCL9 expression in DCs (Fig. 7b) . The accumulation of both LAPC and T FH cells in the dLN were also significantly diminished in the IAV-infected tnfa 2/2 mice (Fig. 7c) . Finally, the adoptive transfer of TNF-a producing non-T FH total T cells (Thy1.2
2 ) isolated from the dLNs of IAV-infected wild type mice at 6 d.p.i. (D6 WT-T, Fig. 5a ) could rescue CXCL9 expression by DCs in tnf-a 2/2 mice. In addition, LAPC and T FH accumulation in the dLNs were restored in tnf-a 2/2 mice following transfer of WT-T cells to levels comparable to that of IAV-infected wild type mice (Fig. 7b  and 7c) . However, the adoptive transfer of il21ra 2/2 T cells, which exhibit significantly diminished TNF-a expression compared to WT-T cells (Fig. 5c) , could not rescue the phenotype in T FH accumulation of tnf-a 2/2 mice (data not shown). Of note, by the repeated experiments, in which the donor wild type CD4 T cells (CD45.1 + ) were distinguished from recipient tnf-a 2/2 CD4 T cells (CD45.2 + ), we confirmed that the rescue of phenotype in T FH accumulation of WT-T cell supplemented tnf-a 2/2 mice was due to the differentiation of recipient tnf-a 2/2 CD4 T cells into T FH cells by the help from donor WT-T cells but not solely reflect T FH differentiation from transferred donor WT-T cells (data not shown). Collectively, these results suggest that IL-21-induced TNF-a production from conventional T cells enhances T FH differentiation in part at least via modulating CXCR3-CXCL9 dependent LAPC migration into the dLN during IAV infection. ). For CD1d-tetramer and T FH marker (PD-1 and CXCR5) staining, either unloaded CD1d-tetramers, isotype control Abs (Rat IgG 2b :RG2b) or secondary Abs (streptavidin-APC:st-APC) has been used as negative controls for CD1d-tetramer, PD-1 or CXCR5 staining, respectively. Representative data from two independent experiments are shown. C57BL/6 (n = 6) and iNKT cell deficient cd-1d Discussion IL-21, first identified as a product of activated human T cells, is a pleiotropic cytokine which has diverse effects on the immune response through its ability to modulate the activity of many immune cell types [23] [24] [25] . Primarily produced by activated CD4 + T cell (in particular, T FH effector cells), IL-21 regulates B cell responses within the B cell follicular germinal center (GC) [25] . NKT cells are an additional potential major source of IL-21 and produce even higher level of this cytokine than activated conventional CD4
+ T cells when appropriately stimulated [22] . As a result of engagement of IL-21Ra/c receptor complex, IL-21 promotes the survival and proliferation, as well as cytokine and chemokine production by multiple immune cell types including macrophages, B, T, NK and NKT cells [24] .
Although CD4 + T FH effector cells are the predominant cell type producing IL-21 during the germinal center response in the dLN, in this model of respiratory virus infection, we find that NKT cells likely are a major source of IL-21 during the early phase of CD4 + T FH effector cell differentiation and GC formation in the dLN. Our unpublished data suggested that there is minimal IL-21 release or expression into the IAV infected lungs before day 5-6 post infection. Indeed, at later stage of infection IL-21 was present in the lung mostly derived from IAV-specific CD4 + T cells entering the infected lungs from the dLN. The stimulus for IL-21 production by the NKT cells responding to IAV infection in the dLN is not as yet defined. NKT cells have been reported to produce IL-21 following antigen receptor engagement or following stimulation by TLR ligands [17, 22, 25] . Since the A/PR/8/34 IAV strain employed in this analysis does not efficiently replicate in the dLN of infected mice, IL-21 production as a result of stimulation of TLR on NKT cells by IAV-derived TLR ligands generated in the dLN seems unlikely. The more likely possibility is that IL-21 is produced by NKT cells following TCR-engagement in response to recognition of lipid moieties released from IAV infected cells.
IL-21 was also initially proposed as an important T cell-derived soluble factor regulating T FH differentiation through engagement of the IL-21R on recently activated CD4 + T cells prior to lineage commitment [8, 11, 13] . Subsequent reports [12, 32] including our findings herein demonstrating a reduced (by , 50%) T FH response in the dLN of IAV-infected il-21ra 2/2 mice (Fig. 1b) further substantiates the contribution of IL21 to T FH differentiation. However, it was unclear whether IL-21 acts directly on naïve/ recently activated CD4
+ T cells to drive T FH differentiation [4, 6, 12] . Indeed, our analysis of T FH responses in mixed BM chimeric mice indicates that when evaluated in the presence of IL-21R signaling competent T cells IL-21R deficient responding CD4 + T cells are fully capable of undergoing T FH differentiation (Fig. 1c) . Therefore, during pulmonary IAV infection at least, there is no intrinsic signal delivered by IL-21 to the responding
CD4
+ T cells in the dLN which is required to program the cells along the T FH differentiation pathway.
Our results suggest a novel and heretofore underappreciated role of IL-21 in regulating T FH differentiation that is through the production of TNF-a. IL-21 either alone or in concert with other cytokines (i.e. IL-7 or IL-15) has been demonstrated to promote TNF-a production most notably from responding T cells [26] [27] [28] . We observed that during IAV infection that the absence of TNF-a resulted in a markedly diminished T FH response ( Fig. 6c and 7c ). In addition, the major source of TNF-a in the responding dLN were T cells whose production of this cytokine required IL-21 and the expression of the IL-21R by the responding T-cells as defective signaling through the IL-21R resulted in significantly decreased TNF-a production by the T-cells (Fig. 5a , 5b and unpublished data).
TNF-a has been demonstrated to play a central role in stimulating chemokine expression at sites of inflammation including CXCL9, which is a strong chemotactic stimulus for mononuclear cells [29] [30] [31] [33] [34] [35] . We observed during IAV infection, that DCs are the major source of CXCL9 in the dLN (Fig. 4b) [16] . Of note, the absence of TNF-a mediated stimulation significantly but not completely diminished CXCL9 production by DCs isolated from the dLN of IAV-infected mice ( Fig. 6b and 7b ). This incomplete inhibition of CXCL9 expression may due to an effect of other soluble factors present in the dLN which are capable of regulating CXCL9 expression in the dLN, most notably, IFN- [34, 35] . CXCL9 production by the dLN DCs was also significantly decreased in IAV-infected IL-21 or IL-21R deficient mice (Fig. 4c and 4d) . However, in our mixed BM chimera study the absence of IL-21R expression on the dLN DC had no direct effect on CXCL9 production by these cells suggesting that the impact of IL21/IL21R signaling on CXCL9 production by the dLN DC was indirect (Fig. 4e) , that is, through the effect of IL-21 on TNF-a production. Even though we cannot rule out the possibility that TNF-a works synergistically with IFNin the dLN to induce CXCL9 expression from DCs [34, 35] , it is unlikely that IL-21 also modulates IFN-expression since both il-21 2/2 and il-21ra 2/2 mice showed no difference in IFN-gene expression in the dLN post-IAV infection (unpublished data).
We believe that the likely link between IL-21/IL-21R signaling, TNF-a production and T FH differentiation is via LAPC. This antigen presenting cell type picks up vial antigen in the IAVinfected lungs, migrate from the lungs into the dLN late in the infection cycle (i.e. between 6 and 12 d.p.i.) where these cells facilitate T FH differentiation of Ag-activated CD4 + T cells. We recently reported that the migration of LAPC into the inflamed dLN is largely CXCR3-CXCL9 dependent [16] . In the current report we find that both IAV infected il-21
2/2 and il-21ra
mice showed significantly diminished (, 60-70%) LAPC migration/accumulation into the dLN (Fig. 3a and 3b) (Fig. 1b and 4a) . Most important, the absence of TNF-a mediated stimulation in vivo during IAV infection, like defective IL-21/IL-21R signaling, resulted in both decreased LAPC migration into the dLN and in a diminished T FH response ( Fig. 6c and 7c) . IL-21 also modulates B cell response which contributes to the maintenance of T FH response [6] . Although B cells are poor inducers for initial T FH differentiation [16] , we cannot rule out the possibility that at the maintenance phase of T FH response during IAV infection (after 9-10 d.p.i.) IL-21, predominantly produced by T FH cells, may also contribute to T FH maintenance via modulating B cells. Although IL-21, TNF-a and CD1d are implicated in anti-IAV T FH /GC-B cell response, we found that deficiency in IL-21 or IL-21R has no effect on virus clearance or recovery from IAV infection in C57BL/6 background (unpublished data). Also, as we reported cd1d deficiency does impact on IL-5 production during IAV infection but does not affect virus clearance or recovery from IAV infection in BALB/c background [36] .
In conclusion, in this report we have identified a novel mechanism, by which IL21 promotes optimal T FH responses in pulmonary virus infection. Our results suggests that during IAV infection IL-21 produced in the dLN early in infection i.e. 5-6 d.p.i. (most likely by NKT cells in the dLN) stimulates TNF-a production by CD4
+ and CD8 + T cells responding to infection in the dLN. The TNF-a stimuli enhances CXCL9 production by dLN resident DCs which in turn acts as a chemotactic stimulus to experiments and presented as percent mTNF-a + cells in the particular cell type. (b & d) C57BL/6 (WT) (n = 9), il-21 2/2 (n = 9) and cd-1d 2/2 mice (n = 6) were infected with 0.05 LD 50 
